Clinical Trials Directory

Trials / Completed

CompletedNCT01390701

Blood Pressure Lowering Effect of Transcutaneous Electrical Nerve Stimulation

Blood Pressure Lowering Effect of Low-frequency Transcutaneous Electrical Nerve Stimulation and Felodipin

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Sahlgrenska University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the blood pressure reducing property of transcutaneous electrical nerve stimulation with the blood pressure reducing drug felodipin.

Detailed description

Hypertension is a major risk factor for development of several vascular complications and is common world wide. Drug treatment is often necessary to achieve adequate blood pressure reduction but blood pressure control in studied countries is unsatisfactory low. Reasons for failure in treatment are several. Among others reasons intolerable side-effects may prevent successful treatment irrespective of the number of drugs. Transcutaneous electrical nerve stimulation (TENS) constitutes no risk of interaction with pharmacological agents and previous studies have reported blood pressure reduction.

Conditions

Interventions

TypeNameDescription
DEVICEtranscutaneous electrical nerve stimulation30 min of bi-daily low-frequency transcutaneous electrical nerve stimulation on the upper extremities. Duration: 28+-4 days.
DRUGfelodipin2,5mg of felodipin once daily. Duration: 28+-4 days.

Timeline

Start date
2008-01-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2011-07-11
Last updated
2011-07-11

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01390701. Inclusion in this directory is not an endorsement.